Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

Yescarta continued to demonstrate durable responses after a median follow-up of more than five years in patients with R/R ...

Dave Coulier’s wife Melissa gave a health update on the ‘Full House’ star’s “difficult” chemotherapy treatment since he was ...

SGX301 has led positive results in early-stage CTCL, with over 70% achieving treatment success in the phase 3 FLASH study.

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...

A panelist discusses how, despite recent advances in relapsed/refractory follicular lymphoma treatment, important unmet needs ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment. Patients with lymphoma or leukemia involving the ...

Cancer research trials at the University of Missouri are helping create a new sense of hope for pet owners whose dogs have ...